179 related articles for article (PubMed ID: 19307488)
1. Prophylactic intravenous immunoglobulin does not have a role in hematopoietic stem-cell transplantation: is the evidence clear?
Reddy N; Goodman S; Savani BN
J Clin Oncol; 2009 May; 27(13):2296-7; author reply 2297-8. PubMed ID: 19307488
[No Abstract] [Full Text] [Related]
2. Summaries for patients. Immunoglobulin in patients with stem-cell transplants.
Ann Intern Med; 2003 Jul; 139(1):I-45. PubMed ID: 12834334
[No Abstract] [Full Text] [Related]
3. Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantation.
Najima Y; Ohashi K; Miyazawa M; Nakano M; Kobayashi T; Yamashita T; Akiyama H; Sakamaki H
Am J Hematol; 2009 May; 84(5):298-301. PubMed ID: 19338041
[TBL] [Abstract][Full Text] [Related]
4. Post-transplant hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment.
Ho V; Momtaz P; Didas C; Wadleigh M; Richardson P
Rev Clin Exp Hematol; 2004 Jun; 8(1):E3. PubMed ID: 16029969
[TBL] [Abstract][Full Text] [Related]
5. Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial.
Cordonnier C; Chevret S; Legrand M; Rafi H; Dhédin N; Lehmann B; Bassompierre F; Gluckman E;
Ann Intern Med; 2003 Jul; 139(1):8-18. PubMed ID: 12834313
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of low-dose heparin and prostaglandin E1 in the prevention of hepatic veno-occlusive disease after allogenic hematopoietic stem cell transplantation in children with beta-thalassemia major].
Sun X; Hao WG; Liu S; Xia T; Liao C
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):343-6. PubMed ID: 17706036
[TBL] [Abstract][Full Text] [Related]
7. [Prophylaxis of hepatic veno-occlusive disease by low-molecular-weight heparin and lipo- prostaglandin E1 after allogeneic peripheral blood stem cell transplantation].
Song CY; Li YH; Guo KY; Wu BY
Di Yi Jun Yi Da Xue Xue Bao; 2003 May; 23(5):494, 497. PubMed ID: 12754143
[TBL] [Abstract][Full Text] [Related]
8. [Liver complications in stem-cell transplantation].
Karthaus M; Meier PN; Manns MP; Ganser A; Hertenstein B
Dtsch Med Wochenschr; 1997 Sep; 122(38):1154-60. PubMed ID: 9378027
[No Abstract] [Full Text] [Related]
9. Optimal approach to prevent veno-occlusive disease following hematopoietic stem cell transplantation in children.
Hassan Z
Pediatr Transplant; 2010 Sep; 14(6):683-7. PubMed ID: 20353406
[No Abstract] [Full Text] [Related]
10. Hepatic veno-occlusive disease following stem cell transplantation: younger patients are not sheltered from this complication.
Busca A
Haematologica; 2005 Oct; 90(10):1302B. PubMed ID: 16219561
[No Abstract] [Full Text] [Related]
11. Hepatic veno-occlusive disease after stem cell transplantation in Japan.
Oh H; Takahashi S; Sakamaki S; Kato S; Okamoto S; Hiraoka A; Kasai M; Maseki N; Dohy H; Kodera Y
Bone Marrow Transplant; 1999 Jul; 24(2):223-4. PubMed ID: 10455356
[No Abstract] [Full Text] [Related]
12. Prophylaxis and treatment of hepatic veno-occlusive disease after pediatric stem cell transplantation.
Tsakiris DA
Haematologica; 2006 Jun; 91(6):726B. PubMed ID: 16769572
[No Abstract] [Full Text] [Related]
13. Venous occlusive disease in children.
Gharib MI; Bulley SR; Doyle JJ; Wynn RF
Thromb Res; 2006; 118(1):27-38. PubMed ID: 16154622
[No Abstract] [Full Text] [Related]
14. Hepatic sinusoidal obstruction syndrome following hematopoietic stem cell transplantation.
Krimmel T; Williams LA
Oncol Nurs Forum; 2008 Jan; 35(1):37-9. PubMed ID: 18192151
[No Abstract] [Full Text] [Related]
15. Hepatic veno-occlusive disease after tranexamic acid administration in patients undergoing allogeneic hematopoietic stem cell transplantation.
Mori T; Aisa Y; Shimizu T; Yamazaki R; Mihara A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Am J Hematol; 2007 Sep; 82(9):838-9. PubMed ID: 17506069
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of hepatic veno-occlusive disease by a combination of heparin and prostaglandin E1 in children undergoing hematopoietic stem cell transplantation].
Inukai T; Sugita K; Goi K; Akahane K; Hirose K; Nemoto A; Takahashi K; Sato H; Uno K; Furuichi Y; Nakamura M; Miyamoto N; Yamakawa N; Shiraishi K; Kojika S; Tezuka T; Iijima K; Nakazawa S
Rinsho Ketsueki; 2004 Apr; 45(4):297-303. PubMed ID: 15168445
[TBL] [Abstract][Full Text] [Related]
17. Origin of macrophages involved in the development of allogeneic hematopoietic stem cell transplantation-associated hemophagocytic syndrome: observations on a patient with juvenile myelomonocytic leukemia.
Ishida H; Yoshida H; Yoshihara T; Ito M; Morimoto A
Bone Marrow Transplant; 2007 Oct; 40(7):701-3. PubMed ID: 17646843
[No Abstract] [Full Text] [Related]
18. Eosinophilic cystitis following cord blood transplantation: a form of acute GVHD. A variant of hemorrhagic cystitis after hematopoietic SCT or drug-induced?
Tasaka T; Matsuhashi Y; Ohnishi H; Kubota Y
Bone Marrow Transplant; 2008 Oct; 42(7):495-6. PubMed ID: 18604241
[No Abstract] [Full Text] [Related]
19. [Sinusoidal obstruction disease (SOS), previous hepatic venoocclusive disease (VOD)--still serious complication after hematopoietic stem cell transplantation].
Gozdzik J; Krasowska-Kwiecień A; Wedrychowicz A
Przegl Lek; 2008; 65(4):203-8. PubMed ID: 18724548
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of sinusoidal obstructive syndrome after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.
Ikezoe T; Togitani K; Komatsu N; Isaka M; Yokoyama A
Bone Marrow Transplant; 2010 Apr; 45(4):783-5. PubMed ID: 19718058
[No Abstract] [Full Text] [Related]
[Next] [New Search]
